Although the SUSTAIN trial programme has provided evidence for the efficacy and safety of semaglutide [18], patients treated with GLP-1 RAs immediately before the study period were not included
297 In particular, extracellular vesicle-mediated transfer of lncRNAs has been shown to activate MAPK signaling and reinforce chemoresistant states in HGSOC
Mounjaros primary function is to improve insulin sensitivity and increase insulin secretion, which helps lower blood glucose
Effect on body weight of subcutaneous semaglutide versus placebo as an adjunct to intensive behavioraltherapy in adults with overweight or obesity: The STEP 3 randomized clinical trial
As indications have expanded from diabetes to obesity, GLP-1RAs have increasingly entered routine care for women of reproductive age, including those with PCOS, in whom obesity and insulin resistance are highly prevalent (36, 38, 43)
The safety profile at weekly dosing is well-established and favorable for most patients